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Abstract 
 
The mechanisms of podocyte disorders in idiopathic nephrotic syndrome (INS) are complex 
and remain incompletely elucidated. Abnormal regulation of NF-κB might play a key role in 
the pathophysiology of these podocyte diseases but it has little been investigated so far. We 
report here that induction of c-mip in podocytes of patients with INS is associated with a 
downregulation of RelA, a potent anti-apoptotic factor belonging to the NF-κB family. 
Overexpression of c-mip in differentiated podocytes promotes apoptosis by inducing 
caspaces-3 activity, an upregulation of the pro-apoptotic protein Bax, while the abundance of 
the anti-apoptotic protein Bcl-2 was decreased. Concomitant overexpression of RelA 
prevented the pro-apoptotic effects of c-mip. We show that targeted induction of c-mip in 
podocytes in vivo inhibits the expression of the RelA protein, and increases the Bax/Bcl2 
ratio. The expression of c-mip and active caspase 3 is increased in FSGS biopsies and both 
proteins display a close spatial relationships. These results suggest that alterations of NF-κB 
activity might result from upregulation of c-mip and likely contribute to podocyte disorders in 
INS. 
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Introduction 
 
Idiopathic nephrotic syndrome (INS) defines several entities including minimal change 
nephrotic syndrome (MCNS), and focal and segmental glomerulosclerosis (FSGS), which are 
considered as prototypic podocyte diseases. 1 Podocytes are terminally differentiated cells that 
line the outer aspect of the glomerular basement membrane (GBM) and constitute the ultimate 
barrier to urinary protein loss by the formation and maintenance of the podocyte foot 
processes (FP) and the interposed slit diaphragm. 2 Podocyte diseases might result from 
genetic defects of proteins playing a key structural and/or regulatory role in the integrity of 
the glomerular filtration barrier. 3 Regardless of the underlying cause, the early podocyte 
damages are characterized by ultrastructural alterations of the slit diaphragm. Cellular injuries 
may progress through a reversilble stage to podocyte depletion and glomerulosclerosis, which 
commonly complicate the outcome of chronic glomerular diseases in INS. In acquired INS, 
the mechanisms preceding these changes remain to be elucidated. 
The NF-κB family of transcription factors plays a central role in many cellular processes 
through the regulation of genes involved in immunity, inflammation, cell proliferation, 
differentiation and apoptosis. In mammalian cells, the NF-κB family consists of five 
members, NF-κB1 (p105/p50), NF-κB2 (p100/p52), RelA (p65), RelB and cRel. 4 The 
hallmark of NF-κB family is the presence in all members of a Rel-homology domain (RHD) 
at the NH2-teminus, responsible for DNA binding, dimerization and association with the I-κB 
inhibitory proteins. 5 Among the NF-κB proteins, only RelA, RelB and c-Rel have a COOH-
terminus transactivation domain, which is lacking in p50 and p52, so that RelA, RelB and c-
Rel homo- or heterodimers, function as transcriptional activators, whereas p50 and p52 
homodimers function as repressors. 4 Although in most cases, Rel proteins act as 
transcriptional activators, they may repress some target genes. 6,7 Because of its implication in 
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many biological processes and the adverse consequences of its dysregulation, the activity of 
NF-κB is tightly regulated at multiple, translational and post-translational levels. The most 
common regulatory mechanism relies on the actions of the inhibitory I-κB proteins. 8 In 
resting cells, I-κB protein binds to nuclear localization site of the RHD, preventing the 
nuclear translocation of NF-κB protein and thereby its transcriptional activity. Upon 
activation, I-κB protein is phosphorylated, which allows its ubiquitination and subsequent 
degradation by proteasome. We recently shown that c-mip interacts with RelA and prevents 
its dissociation from the NFκB/IκBα complexes, resulting in the inhibition of nuclear 
translocation of NFκB and stabilization of IκBα. 9 
In human and experimental glomerular diseases, several mediators regulated by NF-κB such 
as cytokines and adhesion molecules have been reported to play pathogenic roles in 
inflammatory and proliferative glomerular diseases. 10 In non-proliferative glomerular 
diseases, such as minimal change disease and membranous nephropathy, characterized by 
heavy proteinuria, it has been suggested that the excess of proteins in the tubules and their 
subsequent degradation induce tubular expression of many proinflammatory genes through 
NF-κB activation. 11 
To our knowledge, the mechanisms of NF-B regulation in the podocytes are little known. We 
recently reported that c-mip is overproduced in the podocytes during glomerular damages and 
interferes with signaling pathways playing a key role in podocyte function. Whether c-mip 
influences NF-B activity  has not been investigated. 
We report here that c-mip represses in vitro and in vivo NF-κB activity by downregulating the 
expression of RelA. This effect was only observed in podocytes, while tubular cells displayed 
a contrasting increase of NF-kB activity. Moreover, c-mip increases the levels of Bax and 
enhances caspase 3 activity, while it reduces the Bcl-2 level, suggesting that c-mip exerts a 
proapoptotic function. 
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Materials and Methods 
 
Patients 
The diagnosis of kidney disease was carried out by renal biopsy, which was performed 
before the start of treatment. All patients had proteinuria above 3 g/24 h and severe hypo-
albuminemia at the time of blood sampling,. MCNS and FSGS were clinically classified as 
idiopathic in all cases. 
Control for c-mip screening includes adult patients with glomerular diseases (IgA, 
lupus nephritis) who exhibited a nephrotic syndrome. Normal renal samples were supplied by 
the hospital tissue bank (platform of biological resources, Henri Mondor hospital) from 
patients undergoing nephrectomy for polar kidney tumor. 
 
Reverse transcription and real time quantitative PCR (RT-QPCR), and plasmid 
constructs 
The expression plasmids for c-mip and RelA have been previously described. 12,13 Mouse total 
RNA was prepared from glomerular fractions isolated by graded sieving, using RNeasy kit 
(Qiagen, France). RT-QPCR for RelA was performed using the oligonucleotides sense (5’-
TGT TAC CAT CAG GGC AGA TC–3’) and anti-sense (5’-CAG GGT ACT CCA TCA 
GCA TG-3’). The samples (2 µl of the RT reaction mixture, corresponding to 20 ng of total 
RNA) were amplified in a 20-µl reaction mixture containing 0.5 mM of each primer and 1X 
Light Cycler DNA master SYBR green buffer (Roche Molecular Biochemical, Mannheim, 
Germany). RT-QPCR conditions include an initial denaturing step at 95°C for 15 min, 
followed by 40 cycles (denaturing: 95°C, 15 sec; annealing: 59°C, 30 sec; extension, 72°C, 35 
sec).  
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Generation of c-mip stable podocyte cell lines 
Conditionally immortalized mouse podocytes have been described elsewhere. 14 Before 
transfection, podocytes were maintained at 60% confluence, under permissive conditions 
(cells were cultured in RPMI 1640 medium containing 10% FCS, 100 U/ml penicillin, 100 
µg/ml streptomycin, 50 U/ml γ-INF, at 33°C). The full-length human c-mip was inserted into 
pDEST40 plasmid (Invitrogen, Inc, CA). Proliferating podocytes were transfected with c-mip 
expression plasmid (1 µg/106 cells), using the Amaxa system. Following, transfection, cells 
were maintained in complete medium for 24 hours, then geneticin antibiotic was added at 400 
µg/ml (100% lethal to untransfected cells). Stably transfected cells were selected in serial 
passages using geneticin, then stored in liquid nitrogen or expanded under permissive 
conditions in the presence of geneticin until they were in sufficient number. Podocytes clones 
were isolated by limiting dilution and stored in liquid nitrogen. For transient transfection, 
podocytes were transfected with c-mip expression plasmid (pDEST40) alone or cotransfected 
with empty vector or RelA, using the nanofectine method according the instructions provided 
by the manufacturer (PAA, Austria).  In some experiments, podocytes were incubated with 2 
µM lactacystin (Sigma-Aldrich; St Louis, MO) for 20 hours, then protein lysates were 
prepared as previously described 13. 
 
Caspase-3 activity assays.  
Caspase 3 activity was monitored in a quantitative assay using a fluorogenic substrate. 
Podocytes stably tranfected with c-mip or expressing empty vector (~200,000 cells) were 
grown on 60-mm dishes at 37°C for 96 hours. Floating cells were collected and centrifuged, 
and the pellet was lysed in 50 µl of lysis buffer containing 50 mM HEPES, pH 7.4, 100 mM 
NaCl, 1% Nonidet P-40, 1 mM EDTA (pH 8.0), 1 mM dithiothreitol, 2 µg/ml leupeptin, 2 
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µg/ml aprotinin. Adherent cells were washed three times with cold PBS and lysed for 10 min 
on ice in 0.2 ml of lysis buffer. The lysates from adherent and floating cells were pooled and 
centrifuged, and the supernatants were collected. The activity of caspase recognizing the 
DEVD (Asp-Glu-Val-Asp) motif (DEVDase activity) was measured in 200 µl of assay buffer, 
containing 100 mM HEPES, pH 7.4, 10% sucrose, 10 mM dithiothreitol, 500 µM EDTA, 50 
µg of protein, and 20 µM N-acetyl-Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl coumarin 
(AC-DEVD-AFC) as fluorogenic substrate (Biomol, Tebu, France). After 3 h at 37°C, the 
fluorescence of the reaction mixture was monitored every 30 min until seven hours, using a 
spectrofluorometer (FL600 microplate fluorescence reader, Biotek Instruments, Inc, 
Winooski, USA), with excitation and emission wavelengths of 400 and 530 nm, respectively. 
 
TUNEL (Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling) 
assays.  
Paraffin-embedded kidney tissue sections were dewaxed, rehydrated, then treated with 
proteinase K solution (10 µg/ml in 10 mM Tris-HCl, ph7,4) for 30min at room temperature. 
The sections were rinsed twice with PBS and the In Situ Cell Death Detection Kit, POD 
(Roche Diagnostics GmbH, Germany).was used to label apoptotic cells. The sections were 
incubated with 50 µl TUNEL reaction mixture for 60 min at 37oC in a humidified atmosphere 
in the dark. Terminal transferase was omitted for the negative control. As positive control, one 
section was incubated with DNase I (2000 U/ml in 50 mM Tris-HCl, ph 7,5, 10 mM MgCl2 
and 1mg/ml BSA) for 10 min at RT to induce DNA strand breaks, prior the labeling 
procedures. The sections were rinsed 3 times with PBS, then incubated with 50 µl Converter-
POD on sample, for 30min at 37oC. The sections were rinsed 3 times with PBS, then 50 µl of 
DAB substrate and incubated for several minutes at room temperature. Finally, the sections 
were rinsed with PBS, mounted under glass coverslip and analyzed under light microscope. 
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Light microscopy and immunohistochemistry analysis 
For light microscopy, the kidney sections from wild type and c-mip–transgenic mice 
were incubated for 16 hours in Dubosq Brazil, and subsequently dehydrated, paraffin-
embedded and stained with periodic acid-Schiff reagent (PAS). For immunohistochemistry 
study, antigen retrieval was performed by immersing the slides in boiling 0.01 M citrate 
buffer in a 500 W microwave oven for 15 min. The endogenous peroxidase activity was 
blocked with 0,3% H2O2 in methanol for 30 min. Slides were incubated with the blocking 
reagents consisting of the Avidin–biotin solution for 30 min and the normal blocking serum 
for 20 min, then incubated overnight with specific polyclonal antibody. After washing with 
PBS, they were incubated with biotinylated goat anti-rabbit antibody. An avidin-biotinylated 
horseradish peroxidase complex (Vectastain ABC Reagent, Vector Laboratories; Burlingame, 
CA) and 3,3'-diaminobenzidine (Sigma Biochemical; St Louis, MO) as a chromogen were 
applied for visualization of the immunoreaction. The anti RelA, anti-cmip, 13 and anti-cleaved 
caspase 3 (Asp175) were used at a final concentration of 4 mg/ml, or at a 1/200 and 1/50 
dilution, respectively. Omission of the primary antibody was considered as a negative control. 
 
Immunofluorescence 
Immunofluorescence studies on kidney tissues were performed with 4-µm thick cryostat 
sections fixed in acetone for 10 min, air-dried 30 min at room temperature, then kept in PBS 
for 3 min and blocked in 1% BSA-PBS. The sections were incubated with the indicated 
antibodies for one hour at room temperature, washed with PBS and incubated with FITC- or 
red fluorescent dye-conjugated secondary antibodies. For double fluorochrome labeling, the 
slides were simultaneously incubated with rabbit anti-c-mip antibody and mouse anti-nephrin 
antibody. After washing with PBS, the slides were simultaneously incubated with FITC-
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conjugated goat anti-rabbit IgG and cyanine3-conjugated sheep anti-mouse IgG. Sections 
were examined by fluorescence microscopy (Zeiss, Germany) using red and green filters. 
 
Antibodies and Western blotting 
The primary antibodies used in this study included anti-RelA, anti-Tie2, anti-lamin B (Santa 
Cruz, Biotechnology, CA), anti-cleaved caspase 3 (Asp 75), anti-Bax, (cell signaling), anti-
Bcl-2 (BD transduction Laboratories, USA), monoclonal anti-vimentin (Dako, Denmark), 
monoclonal anti-GAPDH (Abcam, Cambridge, UK), anti-actin (Sigma, Aldrich) and anti-
nephrin (Progen, Heidelberg, Germany). The anti-c-mip polyclonal antibody has been 
previously described. 15 Western blotting was performed, using classical methods. 
 
Generation of c-mip transgenic mice 
The generation of c-mip transgenic mice has been previously described. 13 All experiments 
involving animals were conducted in accordance with French laws. . All the mice analyzed in 
this study were hemizygous males [Tg(+)] from the F8 to F12 generations.  
 
Histological analysis 
Morphological lesions were studied on 4 mm PAS-stained sections. Five kidney sections by 
mouse (n= 5 mice for each group) were analyzed. Between 20 and 30 glomeruli per kidney 
section were randomly selected.  
 
Statistical Analysis 
Statistical analysis of the data was performed using PRIZM 4 for Macintosh (Graphpad 
Software, Inc, USA). Unpaired or Paired Student t-tests were used. P value of less than 0,05 
was considered significant. 
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Results 
 
Expression of c-mip is associated with a downregulation of NF-κB in podocytes of 
patients with INS 
Although the role of NF-κB in podocytes is poorly understood, it likely mediates important 
functions including regulation of signaling pathways and podocyte survival. 16 To investigate 
the possible influence of c-mip on NF-κB activity in podocytes of glomerular diseases, we 
studied the kidney biopsies of patients with INS. As previously reported, c-mip was clearly 
induced in kidney biopsies of patients with MCNS, while it was scarcely or not detected in 
normal human kidney. 13 The distribution pattern shows that c-mip was not confined to 
cytoplasmic compartment but it was also visualized in nuclei (Figure 1A). In contrast, we did 
not detect c-mip in glomeruli of IgA nephropathy or proliferative lupus nephritis. 
Immunohistochemistry analysis on the same kidney specimens (five normals and twelve 
MCNS) using an anti-RelA antibody showed that RelA was clearly detected in normal 
podocytes, but it was dramatically altered in the podocytes of MCNS (Figure 1A and 1B). 
Confocal microscopy analysis of normal glomeruli (Fig 2) shows that RelA: i) colocalized 
partially with nephrin but not with Tie2 suggesting that its expression is restricted to 
podocytes; ii) did not overlap with vimentin but mostly colocalized with lamin-B, a marker of 
nuclear membrane. In some podocytes, Rel A was also localized within the nucleus. By 
contrast, in glomeruli of patients with MCNS, the abundance of RelA was lower (Fig 2). 
These results suggest that induction of c-mip in podocytes is associated with a downregulation 
of RelA. 
 
Expression of c-mip in vivo induces a downregulation of RelA at the post-transcriptional 
level 
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To understand the functional consequences of c-mip induction in podocytes, we generated 
transgenic mice expressing c-mip under nephrin promoter to restrict transgene expression to 
podocytes. C-mip-transgenic mice develop heavy proteinuria with foot processes effacement 
without inflammatory lesions or immune complex deposits. 13 The abundance of the RelA 
transcripts measured by quantitative RT-PCR did not significantly differ between wild type 
and transgenic mice (Figure 3A). In contrast, Western blotting of glomerular protein lysates 
showed that RelA abundance was significantly decreased in c-mip-transgenic mice, as 
compared with wild type mice (Figure 3B), which suggests that c-mip affects only the 
stability of the RelA protein. Indeed, coculture of c-mip-transfected podocytes in the presence 
of lactacystin, a potent proteasome inhibiteur, prevented the decrease of endogenous RelA 
(Figure 3C), suggesting that c-mip targets RelA through proteasome-mediated degradation.  
 
C-mip displays proapoptotic properties 
On the basis of the studies carried out in NF-κB-deficient mice, it is believed that NF-κB is a 
potent anti-apoptotic transcription factor. 17 Given our findings showing a downregulation of 
RelA, which is essential for NF-κB activity, we sought to determine whether c-mip influences 
the signaling pathways involved in apoptosis. Apoptosis is defined by morphological features 
including loss of adhesion, cell shrinkage and biochemical alterations such as upregulation of 
Bax and caspase-3 activity. Bax belongs to Bcl-2 family proteins, which include both anti-
apoptotic (e.g. Bcl-2 and Bcl-xl) and pro-apoptotic (e.g. Bax, Bad) members. 18 The caspase-3 
is one of the final downstream effectors of the apoptotic process and its activation is closely 
associated with mitochondrial dysfunction. 19 To assess whether c-mip is a proapoptotic 
molecule, we first transiently transfected c-mip alone in podocyte cell line and analyzed the 
expression level of Bax, Bcl2 and caspase 3. Overexpression of c-mip induced an 
upregulation of Bax and caspase 3, while Bcl2 abundance decreased when compared with 
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empty vector-transfected cells (Figure 4A). On the other hand, co-transfection of RelA 
antagonized the proapoptotic effects of c-mip. Then, we sought whether these changes are 
reproducible in differentiated podocytes stably transfected with c-mip or empty vector. We 
studied five independent c-mip stably transfected podocyte cell lines and two control clones 
stably transfected with empty vector. We performed quantitative Western-blot analysis to 
measure the abundance of the Bcl-2 and Bax proteins that were normalized to GAPDH 
loading. As shown in Figure 4B, Bax was overproduced in c-mip overexpressing podocytes, 
so that the Bax/Bcl-2 ratio was significantly increased (Figure 4B). Morphological analyses 
showed that empty vector-transfected cells displayed small morphological changes, while c-
mip overexpressing podocytes exhibited severe cell shrinkage and most cells had detached. 
To assess whether these morphological changes involve caspase-3 activation, we performed a 
caspase-3 activity assay on stable transfectant cells. Podocytes overexpressing c-mip 
exhibited an activation of caspase-3 in a time-dependent manner, while no significant change 
was detected in the empty vector-transfected podocytes (Figure 4C).  
The relevance of these findings was analyzed in c-mip transgenic mice. In this model, mice 
develop after 3 months of age progressive FSGS. 13 Histological analysis (Figure 5A) showed 
that the number of glomeruli displaying FSGS lesions was increased from three (4 ± 1,5%), 
six (7,5 ± 2,5%) to twelve months of age (23 ± 3,5%). Western-blot analysis from glomerular 
extracts revealed increased Bax in c-mip Tg mice, while Bcl-2 was reduced, with a Bax/Bcl-2 
ratio that was increased by 3,1 fold, as compared with wild type mice (Figure 5B). We then 
used the TUNEL assay to detect DNA fragmentation in podocytes in vivo. In wild-type 
mice and in 3 month-old transgenic mice, TUNEL-positive nuclei were not detectable in 
glomeruli. However, in transgenic mice of 6 and 12 months of age, a number of podocytes 
became positive for TUNEL (Figure 6). Collectively, these results suggest that c-mip 
promotes apoptosis in vitro and in vivo.  
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FSGS lesions are characterized by dysregulation of podocyte function, leading to apoptosis. 
We have previously shown that c-mip abundance is increased in primary FSGS. Therefore, 
we investigated whether FSGS biopsy specimens exhibit active, cleaved caspase 3, a marker 
of cell apoptosis. Immunochemistry analysis was performed in seven FSGS biopsy 
specimens. Active caspase 3 was detected in all examined cases, at a variable degree, along 
the external side of some capillary loops, consistent with podocyte localization (Figure 7). 
The expression was decreased or disappeared in podocyte-depleted areas corresponding to 
severe FSGS lesions or glomerulosclerosis. (Figure 7). Interestingly, c-mip was increased in 
glomeruli in a pattern similar to that observed with active caspase 3.  
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Discussion 
 
The role of NF-κB in glomerular biology and in pathophysiology of podocyte disease remains 
little explored. In the present work, we provide evidence that: i) increased expression of c-mip 
in podocytes of patients with INS is correlated with a downregulation of RelA; ii) c-mip 
destabilizes endogenous RelA protein in vitro, that is prevented by lactacystin, suggesting that 
c-mip targets RelA through proteasome-mediated degradation.; iii) Stable transfection of c-
mip in the podocytes is associated with cell shrinkage and increased abundance of Bax and 
active caspase 3; iv) c-mip induces in vivo an upregulation of Bax and a decrease of Bcl-2, 
supporting the role of c-mip in apoptosis; v) c-mip transgenic mice develop progressive FSGS 
in the absence of overt tubular and interstitial lesions; vi) the abundance of c-mip and active 
caspase 3 was increased in human primary FSGS. 
We have previously shown that c-mip interacts through its PH domain with Fyn and PI3 
kinase regulatory subunit (p85), and exerts an inhibitory role in proximal signaling. 13,20 C-
mip also binds to, and inhibits the activation of N-WASP, a major component of cytoskeleton 
that regulates the ARP2/3-mediated actin nucleation. In addition, we found that c-mip induces 
in vitro and in vivo cytoskeleton disorganization, 13 and increases the abundance of DAP 
kinase. 20 It has been shown that DAP kinase promotes apoptosis by disrupting integrin–
mediated cell adhesion, alteration of cytoskeleton and loss of extracellular matrix-dependent 
survival signals. 21 Alteration of the actin network induces the production of reactive oxygen 
species (ROS) from mitochondria, leading to apoptosis. 22 We have previously found that c-
mip binds RelA through its LRR-containing C-terminal domain. 9 We show here that c-mip 
may target RelA to proteasome-dependent degradation. Altogether, our results suggest that c-
mip is a multifunctional protein and may promote apoptosis through different mechanisms, 
including cytoskeleton alterations, upregulation of DAP kinase and downregulation of RelA.   
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Several studies have shown that NF-κB hyperactivation is mainly correlated with the intensity 
of proteinuria and is restricted in the tubules of patients with progressive kidney diseases, 
including glomerular diseases. 23-25 Indeed, NF-κB activity is associated with increased 
tubular expression of the chemokines MCP-1, RANTES, osteopontin and the profibrogenic 
cytokines PDGF-BB and TGFβ, 23 leading to tubular apoptosis and fibrosis. In contrast, these 
studies fail to detect significant hyperactivation of NF-κB in podocyte in certain forms of 
glomerular diseases, suggesting that this mechanism does not prevail in these cells. It has 
been reported that NF-κB is expressed in a few mesangial cells and tubular epithelial cells in 
MCNS and MN, while it is detected in podocytes of IgA nephropathy and non-IgA mesangial 
proliferative glomerulonephritis. 24 These data are consistent with our results because the 
upregulation of c-mip might account for the non-detection of NF-κB in podocytes in INS. 
Conversely, in IgA nephropathy where the expression of NF-κB is found increased, c-mip 
was not detected in podocytes, according with previous data. 13 The downregulation of RelA 
in INS relapse may explain why these podocyte diseases are not associated with inflammatory 
processes in glomeruli. By contrast, activation of RelA in the podocytes of Par4-deficient 
mice is associated with severe glomerular and tubular inflammatory lesions. 26 Moreover, in 
pathological situations associated with sustained c-mip increase, the downregulation of NF-
κB in glomeruli might represent a possible mechanism involved in podocyte apoptosis and 
may contribute to podocyte depletion in some podocyte diseases without early involvement of 
tubular and interstitial tissue injuries. 
Two distinct signaling pathways are involved in the initiation of apoptosis: i) the extrinsic 
apoptotic pathway or receptor–linked pathway requires the binding of a ligand to a death 
receptor on the cell surface, such as TNF receptor; ii) the intrinsic apoptotic pathway that is 
mediated by mitochondrial damage and release of cytochrome C. 27 The development of the 
signaling cascade leading to apoptosis requires in most situations the upregulation of p53. 
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Despite several assays, we did not observe an upregulation of p53 in stable transfected 
podocytes overexpressing c-mip or in c-mip Tg mice (data not shown), which suggests that 
the proapoptotic function of c-mip does not require p53. Some studies have shown that the 
ability to trigger apoptotic pathways in the absence of p53 may result from the activation of 
Erk signaling. 28 However, the Erk pathway has multiple functions including pro and anti-
apoptotic effects of which the mechanisms are still unclear. 29 
Induction of apoptosis following exposition to puromycin aminonucleoside (PAN), in 
cultured podocytes as well as in vivo, in a model of FSGS in rats, is associated with an 
increase of Bax and a reduction of Bcl-2. 19,30  The underlying mechanism involves an 
upregulation of p53 since, in this model, apoptosis is prevented by PFT-α and 
dexamethasone, which inhibit p53 activation. Indeed, two signaling pathways have been 
involved in podocyte apoptosis induced by PAN, depending of caspase-3 or apoptosis-
inducing factor (AIF), respectively. Dexamethasone inactivates AIF by inhibiting its nuclear 
translocation. 19  
It has been shown that insulin growth factor-1 (IGF-1) protects from apoptosis induced by 
etoposide, an inhibitor of topoisomerase II, through a mechanism involving activation of PI3 
kinase and Bad. 31 This conclusion is based on the fact that the inhibitors of PI3 kinase, 
Whormaninn and Ly294002, abrogate the anti-apoptotic effect of IGF1. Moreover, nephrin 
and VEGF inhibit apoptosis by recruiting the PI3 kinase-Akt signaling pathway. 32 Both 
VEGF and nephrin signaling pathways appear interconnected because mutation of nephrin, 
which disrupts the nephrin signaling, abrogates the anti-apoptotic effect of VEGF. 32 
The anti-apoptotic role of CD2AP, an adapter protein anchoring the nephrin-mediated 
proximal signals to actin cytoskeleton, has been evidenced by the phenotype of CD2AP-
deficient mice, which develop nephrotic syndrome and renal failure caused by 
glomerulosclerosis. 33 In this model, proteinuria occurs in the context of accelerated apoptosis 
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resulting from hyperactivation of p38 mitogen activated protein kinase (p38 MAPK) by 
TGFβ1. 34,35 The mechanism by which CD2AP impedes the apoptotic process involves a 
downregulation of p38 MAPK via activation of PI3 kinase and Akt signaling. 35  
Direct evidence of the role of TGFβ1 in podocyte apoptosis comes from study of transgenic 
mice overexpressing TGFβ1 under control of the albumin promoter. 36 In this model, Tg mice 
display glomerulosclerosis and interstitial fibrosis with renal failure and death in 50% of 
offspring at 5-12 weeks of age. 34 Histological lesions observed in TGFβ1 and c-mip Tg 
models are different. Glomerulosclerosis and ECM expansion are present in the early stages 
(~ 2 weeks) in TGFβ1 Tg mice, while glomeruli are morphologically normal despite the 
presence of a nephrotic syndrome and foot process fusions in c-mip Tg mice, until 4-5 months 
of age. Renal failure and death are rare during the first year of live in c-mip Tg mice even 
though these complications are common in TGFβ1 Tg mice. However, like for c-mip Tg 
mice, podocyte apoptosis precedes mesangial expansion.  
In conclusion, we reported here new functional aspects of c-mip in podocytes. We show that 
c-mip induces in vitro and in vivo the destabilization of the RelA protein in podocytes. The 
upregulation of c-mip and active caspase 3 in human FSGS suggest that sustained 
upregulationn of c-mip might result in podocyte depletion and progressive FSGS.  
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Legends 
 
Figure 1. Induction of c-mip in MCNS relapse is associated with a downregulation of 
RelA. Representative immunohistochemical analysis of serial sections from normal human 
kidney (NHK) and kidney biopsy specimens. A: Expression of c-mip. Note that c-mip was 
below detection limits in normal glomeruli, while it was clearly visualized along the external 
side of the capillary loops of MCNS relapse. The expression of c-mip was not restricted to 
cytoplasm compartment but it is also distributed in the nuclei. Note that c-mip was not 
detected  in IgA or in proliferative lupus nephritis. Scale bars, 20 mm. B: Expression of RelA. 
Note that RelA is highly abundant in normal podocytes, while it was reduced in MCNS 
relapse. Scale bars, 20 mm. 
 
Figure 2. Confocal microscopy analysis.  Detection of RelA (green) and nephrin, tie-2, 
vimentin, and lamin-B (red) in normal human kidney (NHK, left panel) and kidney biopsy 
specimens from MCNS relapse (right panel). Note that RelA partially colocalized with 
nephrin and lamin- but not with vimentin and tie-2 in normal glomeruli. The expression of 
RelA was hardly detected in MCNS relapse. Scale bars, 20 mm. 
 
Figure 3. The RelA protein is destabilized in the presence of c-mip, in vivo and in vitro. 
Glomeruli from wild-type (WT, n=5) and 6 month-old c-mip transgenic mice [Tg(+), n=5] 
were isolated and the abundance of RelA was analyzed. A: Quantification of RelA transcripts 
by RT-QPCR. B: Quantitative Western blotting of RelA protein. Data are representative of 
three independent experiments. C: Podocytes were transiently transfected with c-mip or 
empty vector (Ev), cultured 20 hours with or without lactacystin (2 mM), then analyzed by 
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Western blotting. Note that lactacystin prevents the destabilization of endogenous RelA. Data 
are representative of two independent experiments. 
 
Figure 4. Transient and stably overexpression of c-mip in podocytes promote apoptosis. 
A, Podocytes were singly transiently transfected with empty vector (Ev) and c-mip or 
cotransfected with Ev/c-mip or RelA/c-mip. The expression of Bax, Bcl2 and caspase 3 was 
analyzed by Western blotting on the protein lysates. Note that c-mip increases Bax and 
caspase 3 and downregulates Bcl2, these alterations being prevented by the coexpression of 
RelA. B, Podocytes were stably transfected with c-mip expression plasmid (pDest 40) or 
empty vector (Ev), then cloned by limiting dilution. Morphological and/or quantitative 
western blot data for six clones (five c-mip and one Ev clones) are shown. c-mip was revealed 
by anti-V5 tag monoclonal antibody. Quantification of c-mip was carried out by subtracting 
the background related to the empty vector. Note that c-mip abundance varies depending of 
the clone; higher c-mip abundance is correlated with severe cellular injury and an increase of 
the Bax/Bcl2 ratio. C, Differentiated podocytes stably transfected with c-mip or empty vector 
(Ev) were tested for caspase 3 activity assays. The caspase 3 activity was monitored every 30 
min during seven hours.  
 
Figure 5. C-mip promotes progressive FSGS in transgenic mice. A, left, Representative 
Periodic acid-Schiff (PAS) staining of kidney sections from 3 to 12 month-old wild type and 
proteinuric Tg mice. Scale bars: left: 50 mM, right, 20 mM. Glomerular alterations are 
apparent at 6 and 12 months characterized by FSGS lesions and mesangial expansion. The 
tubules appear normal and no inflammatory injuries can be seen. Right, percentage of 
glomeruli with FSGS. Five mice were analyzed by age range (≥ 300 glomeruli). Data 
represent the mean ± SEM. B, glomerular protein extracts from 12 month-old wild type and 
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proteinuric Tg mice were analyzed by Western blotting for the relative expression of Bax and 
Bcl-2;  
 
Figure 6. c-mip promotes apoptosis in vivo. Terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling (Tunel) assay on paraffin kidney sections of wild-type and 
c-mip transgenic mice. Note that tunnel positive cells were not detected in 3 month-old 
transgenic mice, whereas many podocytes became positive at 6 months of age 
 
Figure 7. Expression of c-mip and caspase 3 in FSGS biopsies. Representative 
Immunostaining of c-mip and cleaved caspase 3 from FSGS biopsy specimens. In most cases, 
the localization of c-mip and active caspase 3 are observed in close proximity. The labels 
strongly decreases or disappears in podocyte-depleted areas corresponding to FSGS lesions or 
severe glomerulosclerosis. Scale bars, 20 mm. 
 
 
 







